(Report) Seminar “Solution for Global Health Issues -Public and Private Partnership-“
date : 11/5/2013
In recent years, there has been rapid economic growth in some developing countries which is seen as a new market opportunity for businesses, however, these
countries are disadvantaged by their limited access to medical resources. In particular they are significantly handicapped by the three major infectious
diseases i.e. HIV/AIDS, Tuberculosis, Malaria, and NTD (Neglected Tropical Diseases).
As public funding is limited, an innovative business model called “Public-Private-Partnership”(PPP) plays an important role in solving global health issues
in developing countries. PPP is a government service or private business venture which is funded and operated through a partnership of government and one or
more private sector companies.
In the first session of the current sequential seminars, we would like to hold discussion about why PPP has drawn great attention especially in the global
health field. By introducing examples of PPP by The Global Health Innovative Technology Fund (GHIT Fund,) which aims to solve global health issues, we
discussed how government and private sector companies can cooperate and maximize the partnership. The GHIT Fund is a non-profit organization aimed at
promoting the discovery and development of new health technologies including drugs, vaccines and diagnostics for infectious diseases prevalent in developing
counties.The first partnership of its kind in Japan, the GHIT Fund is a PPP established by the Government of Japan, a consortium of Japanese pharmaceutical
companies and the Bill & Melinda Gates Foundation in 2012. Through the session, we discussed and explored sustainable ways of contributing to global health
solutions with speakers and audience participation.
*Language: Japanese
■Date and Time
Oct 23, 2013 19:00-21:00
■Venue
ARK HILLS Club
37F East Wing, ARK Mori Building,
1-12-32 Akasaka, Minato-ku, Tokyo
■Theme
“Global Health and Public-Private Partnership”
■Speaker
-Kiyoshi Kurokawa
Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute / Chair of the Board & Representative Director,
Global Health Innovative Technology Fund
-Kei Katsuno
Derector of Strategy, Global Health Innovative Technology Fund
■Fee
1,500 Yen (Student 1,000yen(Please show your school identification card.))
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Monday, Oct 21th, 2013. When the seats are fully booked,
we may stop accepting applications.
■Organizer
Health and Global Policy Institute
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by
generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and
to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to
activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand
choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and
different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies
for the developing world.
The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and
the Bill & Melinda Gates Foundation.
The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious
diseases. The goals is to facilitate and fund
global health R&D partnerships that can generate new drugs, vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing
world.
■Cooperated with
MORI HOSPITALITY CORPORATION
■Secretariat
Health and Global Policy Institute
Tel: 03-5511-8521
Email: info@hgpi.org
countries are disadvantaged by their limited access to medical resources. In particular they are significantly handicapped by the three major infectious
diseases i.e. HIV/AIDS, Tuberculosis, Malaria, and NTD (Neglected Tropical Diseases).
As public funding is limited, an innovative business model called “Public-Private-Partnership”(PPP) plays an important role in solving global health issues
in developing countries. PPP is a government service or private business venture which is funded and operated through a partnership of government and one or
more private sector companies.
In the first session of the current sequential seminars, we would like to hold discussion about why PPP has drawn great attention especially in the global
health field. By introducing examples of PPP by The Global Health Innovative Technology Fund (GHIT Fund,) which aims to solve global health issues, we
discussed how government and private sector companies can cooperate and maximize the partnership. The GHIT Fund is a non-profit organization aimed at
promoting the discovery and development of new health technologies including drugs, vaccines and diagnostics for infectious diseases prevalent in developing
counties.The first partnership of its kind in Japan, the GHIT Fund is a PPP established by the Government of Japan, a consortium of Japanese pharmaceutical
companies and the Bill & Melinda Gates Foundation in 2012. Through the session, we discussed and explored sustainable ways of contributing to global health
solutions with speakers and audience participation.
*Language: Japanese
■Date and Time
Oct 23, 2013 19:00-21:00
■Venue
ARK HILLS Club
37F East Wing, ARK Mori Building,
1-12-32 Akasaka, Minato-ku, Tokyo
■Theme
“Global Health and Public-Private Partnership”
■Speaker
-Kiyoshi Kurokawa
Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute / Chair of the Board & Representative Director,
Global Health Innovative Technology Fund
-Kei Katsuno
Derector of Strategy, Global Health Innovative Technology Fund
■Fee
1,500 Yen (Student 1,000yen(Please show your school identification card.))
■Application Procedure
Please complete the online procedure on the Health and Global Policy Institute website by noon on Monday, Oct 21th, 2013. When the seats are fully booked,
we may stop accepting applications.
■Organizer
Health and Global Policy Institute
Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policies by
generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and
to foster as sustainable healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to
activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand
choices and benefits in a global, long-term perspective. HGPI promotes a Global Citizen Nation by building a society for people with various backgrounds and
different values. It aims to achieve a sustainable, healthy, and more prosperous world.
Global Health Innovative Technology Fund
The Global Health Innovative Technology Fund (GHIT Fund) is Japan’s first public-private partnership to advance the development of new health technologies
for the developing world.
The first product development fund of its kind in Japan, the GHIT Fund was created by the Japanese Government, Japan’s leading pharmaceutical companies, and
the Bill & Melinda Gates Foundation.
The GHIT Fund is bringing Japanese leadership in health and technology innovation from its public and private sectors to the global fight against infectious
diseases. The goals is to facilitate and fund
global health R&D partnerships that can generate new drugs, vaccines and diagnostics and other tools for fighting neglected diseases prevalent in developing
world.
■Cooperated with
MORI HOSPITALITY CORPORATION
■Secretariat
Health and Global Policy Institute
Tel: 03-5511-8521
Email: info@hgpi.org
Exhibition date：2013-10-23
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
![[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)](https://hgpi.org/en/wp-content/uploads/sites/2/hs130-top_JPNENG-1.png)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
![[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/hs129-top.png)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
![[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/160f1c0c260ce6021440137773571fc9.png)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
![[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20241206_PolicyColumn_eyecatch.png)
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)
![[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20241023_FY2024CKD_eyecatch.jpg)
